RX871024 is an experimental drug containing an imidazoline moiety, developed by Reckitt Benckiser. The development of RX871024 was discontinued in 1997. It is known for its potent ability to enhance insulin action.
The compounds of every Wikipedia article carrying a Chembox or a Drugbox, refreshed daily, with the values their infoboxes give. The pages need JavaScript; the API does not.